MKS Instruments, Inc. provides instruments, systems, subsystems, and process control solutions that measure, monitor, deliver, analyze, power, and control critical parameters of manufacturing processes worldwide.
MKS Instruments, Inc. provides instruments, systems, subsystems, and process control solutions that measure, monitor, deliver, analyze, power, and control critical parameters of manufacturing processes worldwide. Its Vacuum & Analysis segment offers pressure and vacuum control solutions, including direct and indirect pressure measurement; materials delivery solutions comprising flow and valve technologies, as well as integrated pressure measurement and control subsystems, which provide customers with precise control capabilities; power solutions products, such as microwave, power delivery systems, radio frequency matching networks, and metrology products used in providing energy to etching, stripping, and deposition processes; and plasma and reactive gas products. Its Light & Motion segment offers laser products, such as continuous wave and pulsed nanosecond, diode and diode-pumped solid-state, and fiber laser technologies; and photonics products comprising motion control, optical tables and vibration isolation systems, photonic instruments, optics and optical assemblies, opto-mechanical components, temperature sensing products for wafer fabrication systems, and laser and LED measurement products, including laser power and energy meters, laser beam profilers, and optical and photonic subsystems.
MKS Instruments Fundamentals Summary
How do MKS Instruments's earnings and revenue compare to its market cap?
Is MKS Instruments undervalued compared to its fair value and its price relative to the market?
Valuation Score
5/6
Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry
38.0%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: MKSI ($117.51) is trading below our estimate of fair value ($189.5)
Significantly Below Fair Value: MKSI is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: MKSI is good value based on its PE Ratio (11.4x) compared to the US Semiconductor industry average (19.8x).
PE vs Market: MKSI is good value based on its PE Ratio (11.4x) compared to the US market (15.2x).
Price to Earnings Growth Ratio
PEG Ratio: MKSI is poor value based on its PEG Ratio (1.5x)
Price to Book Ratio
PB vs Industry: MKSI is good value based on its PB Ratio (2.2x) compared to the US Semiconductor industry average (3.5x).
Future Growth
How is MKS Instruments forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?
Future Growth Score
1/6
Future Growth Score 1/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
7.9%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MKSI's forecast earnings growth (7.9% per year) is above the savings rate (1.9%).
Earnings vs Market: MKSI's earnings (7.9% per year) are forecast to grow slower than the US market (12.5% per year).
High Growth Earnings: MKSI's earnings are forecast to grow, but not significantly.
Revenue vs Market: MKSI's revenue (4% per year) is forecast to grow slower than the US market (7.8% per year).
High Growth Revenue: MKSI's revenue (4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MKSI's Return on Equity is forecast to be low in 3 years time (14%).
Past Performance
How has MKS Instruments performed over the past 5 years?
Past Performance Score
4/6
Past Performance Score 4/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
12.7%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MKSI has high quality earnings.
Growing Profit Margin: MKSI's current net profit margins (19.1%) are higher than last year (16.2%).
Past Earnings Growth Analysis
Earnings Trend: MKSI's earnings have grown by 12.7% per year over the past 5 years.
Accelerating Growth: MKSI's earnings growth over the past year (42%) exceeds its 5-year average (12.7% per year).
Earnings vs Industry: MKSI earnings growth over the past year (42%) underperformed the Semiconductor industry 70.4%.
Return on Equity
High ROE: MKSI's Return on Equity (18.9%) is considered low.
Financial Health
How is MKS Instruments's financial position?
Financial Health Score
6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage
Financial Position Analysis
Short Term Liabilities: MKSI's short term assets ($2.3B) exceed its short term liabilities ($436.0M).
Long Term Liabilities: MKSI's short term assets ($2.3B) exceed its long term liabilities ($1.2B).
Debt to Equity History and Analysis
Debt Level: MKSI has more cash than its total debt.
Reducing Debt: MKSI's debt to equity ratio has reduced from 43.1% to 27% over the past 5 years.
Debt Coverage: MKSI's debt is well covered by operating cash flow (67.7%).
Interest Coverage: MKSI's interest payments on its debt are well covered by EBIT (30.2x coverage).
Balance Sheet
Dividend
What is MKS Instruments's current dividend yield, its reliability and sustainability?
Dividend Score
0/6
Dividend Score 0/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage
0.75%
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: MKSI's dividend (0.75%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.58%).
High Dividend: MKSI's dividend (0.75%) is low compared to the top 25% of dividend payers in the US market (4.11%).
Stability and Growth of Payments
Stable Dividend: MKSI is not paying a notable dividend for the US market, therefore no need to check if payments are stable.
Growing Dividend: MKSI is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.
Earnings Payout to Shareholders
Earnings Coverage: MKSI is not paying a notable dividend for the US market.
Cash Payout to Shareholders
Cash Flow Coverage: MKSI is not paying a notable dividend for the US market.
Discover strong dividend paying companies
Management
How experienced are the management team and are they aligned to shareholders interests?
3.3yrs
Average management tenure
CEO
John T. Lee (58 yo)
4yrs
Tenure
US$7,638,355
Compensation
Dr. John T. C. Lee serves as Director of Cognex Corporation since May 2022. He has been the President of MKS Instruments, Inc. since May 2018 and Chief Executive Officer and Director since January 1, 2020....
CEO Compensation Analysis
Compensation vs Market: John T.'s total compensation ($USD7.64M) is about average for companies of similar size in the US market ($USD8.23M).
Compensation vs Earnings: John T.'s compensation has increased by more than 20% in the past year.
Leadership Team
Experienced Management: MKSI's management team is considered experienced (3.3 years average tenure).
Board Members
Experienced Board: MKSI's board of directors are considered experienced (3 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
MKS Instruments, Inc.'s employee growth, exchange listings and data sources
All financial data provided by Standard & Poor's Capital IQ.
Data
Last Updated (UTC time)
Company Analysis
2022/05/22 00:00
End of Day Share Price
2022/05/20 00:00
Earnings
2022/03/31
Annual Earnings
2021/12/31
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.